Targeted knockdown of SEPT9_v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples